Insider Transactions in Q2 2021 at Phathom Pharmaceuticals, Inc. (PHAT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
13,960
-1.1%
|
$474,640
$34.0 P/Share
|
|
Jun 28
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
26,040
-1.0%
|
$885,360
$34.58 P/Share
|
|
Jun 28
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
370
-0.04%
|
$12,950
$35.08 P/Share
|
|
Jun 25
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
24,131
-1.33%
|
$844,585
$35.76 P/Share
|
|
Jun 24
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,848
-1.18%
|
$379,680
$35.14 P/Share
|
|
Jun 23
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200
-0.02%
|
$7,000
$35.0 P/Share
|
|
Jun 22
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.0 P/Share
|
|
Jun 21
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,294
-1.0%
|
$325,290
$35.31 P/Share
|
|
Jun 18
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,398
-0.58%
|
$188,930
$35.13 P/Share
|
|
Jun 17
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,305
-0.35%
|
$115,675
$35.08 P/Share
|
|
Jun 14
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,826
-0.3%
|
$98,910
$35.06 P/Share
|
|
Jun 10
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,102
-0.22%
|
$73,570
$35.14 P/Share
|
|
Jun 09
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,191
-0.13%
|
$41,685
$35.28 P/Share
|
|
Jun 08
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.0 P/Share
|
|
Jun 07
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,264
-0.24%
|
$79,240
$35.05 P/Share
|
|
Jun 02
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,300
-0.45%
|
$150,500
$35.18 P/Share
|
|
Jun 01
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,211
-0.59%
|
$392,385
$35.88 P/Share
|
|
May 28
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,905
-0.31%
|
$320,580
$36.44 P/Share
|
|
May 27
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,453
-0.43%
|
$312,761
$37.27 P/Share
|
|
May 26
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,358
-0.63%
|
$444,888
$36.68 P/Share
|
|
May 25
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,947
-0.55%
|
$394,092
$36.38 P/Share
|
|
May 24
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,594
-0.52%
|
$370,790
$35.84 P/Share
|
|
May 21
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,648
-1.14%
|
$407,680
$35.74 P/Share
|
|
May 20
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,098
-0.69%
|
$248,430
$35.1 P/Share
|
|
May 20
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
3,482
-0.09%
|
$118,388
$34.65 P/Share
|
|
May 19
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
36,518
-0.92%
|
$1,168,576
$32.71 P/Share
|
|
May 14
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.0 P/Share
|
|
May 13
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.33 P/Share
|
|
May 12
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,776
-0.57%
|
$412,160
$35.73 P/Share
|
|
May 07
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,011
-0.1%
|
$35,385
$35.03 P/Share
|
|
May 06
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
202
-0.02%
|
$7,070
$35.01 P/Share
|
|
May 05
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,936
-0.66%
|
$242,760
$35.14 P/Share
|
|
May 04
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
19,360
-0.46%
|
$696,960
$36.93 P/Share
|
|
May 04
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
4,457
-0.19%
|
$164,909
$37.03 P/Share
|
|
May 03
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,632
-0.45%
|
$556,016
$38.37 P/Share
|
|
May 03
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
10,043
-0.65%
|
$381,634
$38.22 P/Share
|
|
Apr 06
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
17,882
-0.33%
|
$643,752
$36.58 P/Share
|
|
Apr 05
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
22,118
-0.54%
|
$796,248
$36.41 P/Share
|
|
Apr 05
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
9,353
-0.4%
|
$336,708
$36.38 P/Share
|
|
Apr 01
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
5,147
-0.32%
|
$190,439
$37.71 P/Share
|